Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


7th Annual Improving Solubility Conference

26 Feb 2013 - 28 Feb 2013 - Philadelphia, PA, USA



Bookmark and Share


IQPC’s Improving Solubility Conference has become an annual meeting for the scientific community. This year, we will showcase the newest solubility technologies and provide the latest research from established industry leaders in order to provide you with practical, applicable knowledge to effectively improve bioavailability and drug candidate solubility.

The competition in the pharmaceutical market is at an all time high and without solid techniques to drive increased bioavailability of your products, you will be left in the dust. Learn the latest methodologies and technologies to take on this challenge and minimize the time-to-market on your drug pipeline.

Gain access to exclusive case studies on:

•    Approaches to Leverage In-Vitro Data to Hypothesize In-Vivo Data
•    Rational Formulation Design Guided by Biopharmaceutics Modeling and Automated Formulation Screening
•    Designing and Developing Super Saturation Based Drugs
•    Enhancing the In-Vivo Performance Hot-Melt Extrusion
•    Introducing Levitation Technology for the Production of Amorphous Drugs
•    Co-Crystal Development: From Mortar & Pestle to Production
•    Influence of Particle Size on the Ultraviolet Spectrum of Particulate-Containing Solutions
•    Stability Prediction for Amorphous Materials



Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!